Loading

Commentary Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.46439/pediatrics.2.019

Congenital Cytomegalovirus screening in newborns: Current status in the United States

  • 1Professor of Pediatrics, Albert Einstein College of Medicine, Division of Neonatology, Children’s Hospital at Montefiore, 1825 Eastchester Road, Bronx, NY 10461, USA
+ Affiliations - Affiliations

Corresponding Author

Suhas M Nafday, snafday@montefiore.org

Received Date: September 26, 2021

Accepted Date: November 15, 2021

Abstract

Targeted hearing screening for congenital cytomegalovirus (cCMV) with CMV polymerase chain reaction testing completed before 3 weeks of age for infants who fail newborn hearing screening is a reasonable option to improve cCMV related non-genetic sensory-neural hearing loss (SNHL). Universal cCMV screening using dried blood spots that is used on almost newborn infants has the potential to benefit those children at risk for SNHL and will be a great public health option.

Keywords

Congenital cytomegalovirus screening, Newborn, Sensorineural hearing loss

Author Information X